23andMe plans to move beyond genetic testing to making drugs
Genetic testing company 23andMe wants to use the vast amounts of genetic data it has gathered over the last few years to start making drugs, according to Bloomberg. Instead of focusing on screening people for various diseases, the company plans to make therapeutic agents that will target these diseases and possibly cure them. It’s a pretty big departure for the company that failed to get FDA approval for its DNA testing kit and that only just received FDA clearance to sell a test that looks for markers of Bloom Syndrome, a rare genetic condition that’s associated with sun sensitivity and increased cancer risk.
Source:: The Verge
